Sun Pharmaceutical (SUNPHARMA) — Board Meeting

Sun Pharmaceutical's board approved a ₹3,000 crores greenfield investment through wholly-owned subsidiary Sun Pharma Laboratories Limited to establish a formulations manufacturing facility in Madhya Pradesh. This capacity expansion represents significant capital deployment for manufacturing scale-up in India's pharmaceutical sector.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this board meeting affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 2 December 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 2 December 2025

CANBK Canara Bank Corporate Action CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action AMBUJACEM Ambuja Cements Limited Corporate Action SIEMENS Siemens Limited Announcement AXISBANK Axis Bank Limited Corporate Action ICICIPRULI ICICI Prudential Life Insurance Company Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.